[1]BiochemicalJournal,1931,vol.25,p.619
[1]JournalofBiologicalChemistry,1931,vol.94,p.244
[1]JournalofBiologicalChemistry,1956,vol.218,p.449,450
Title: The new oral immunomodulating drug DiNAC induces brachial artery vasodilatation at rest and during hyperemia in hypercholesterolemic subjects, likely by a nitric oxide-dependent mechanism.
Journal: Atherosclerosis 20080101
Title: N,N-diacetyl-L-cystine improves endothelial function in atherosclerotic Watanabe heritable hyperlipidaemic rabbits.
Journal: Basic & clinical pharmacology & toxicology 20070101
Title: Influence of N,N'-diacetyl-L-cystine on D-galactosamine/lipopolysaccharide induced immunological liver failure in mice.
Journal: Yao xue xue bao = Acta pharmaceutica Sinica 20041001
Title: The antiatherogenic effect of DiNAC: experimental findings supporting immunomodulation as a new treatment for atherosclerosis related diseases.
Journal: Cardiovascular drug reviews 20030101
Title: Immunomodulation with DiNAC-- a new approach to the treatment of atherosclerosis?
Journal: Expert opinion on investigational drugs 20020501
Title: N,N'-diacetyl-L-cystine (DiNAC), the disulphide dimer of N-acetylcysteine, inhibits atherosclerosis in WHHL rabbits: evidence for immunomodulatory agents as a new approach to prevent atherosclerosis.
Journal: The Journal of pharmacology and experimental therapeutics 20011001
Title: Monitoring of the subtraction process in solid-phase representational difference analysis: characterization of a candidate drug.
Journal: Gene 20010627
Title: Wågberg M, et al. N,N'-diacetyl-L-cystine (DiNAC), the disulphide dimer of N-acetylcysteine, inhibits atherosclerosis in WHHL rabbits: evidence for immunomodulatory agents as a new approach to prevent atherosclerosis. J Pharmacol Exp Ther. 2001 Oct;299(1):76-82.
Title: Särnstrand B, et al. N,N'-Diacetyl-L-cystine-the disulfide dimer of N-acetylcysteine-is a potent modulator of contact sensitivity/delayed type hypersensitivity reactions in rodents. J Pharmacol Exp Ther. 1999 Mar;288(3):1174-84.
